Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Trovagene and Nerviano Announce License Agreement for therapeutic candidate PCM-075
Thursday, March 16, 2017Trovagene Inc a precision medicine biotechnology company and Nerviano Medical Sciences Srl a leading oncology discovery organization today announced that they have signed a license agreement that grants Trovagene exclusive global development and comm...
AMO Pharma Enters into Collaboration Agreement with Ranedis Pharmaceuticals
Wednesday, March 15, 2017AMO Pharma Limited a privately held biopharmaceutical company focusing on debilitating diseases with limited or no treatment options today announced it has entered a collaboration agreement with Ranedis Pharmaceuticals a privately held US biopharmace...
Pfizer Launches Zavicefta™ (ceftazidime-avibactam) in the U.K. and Germany
Wednesday, March 15, 2017Pfizer Inc announced that Zavicefta a novel combination antibiotic for the treatment of patients with certain confirmed or suspected Gramnegative bacterial infections requiring hospitalization is now available in the UK and Germany Pfizer expects to...
Biocept and Catalyst Pharmaceuticals Collaborate to Provide Liquid Biopsy Testing for Small Cell Lung Cancer
Wednesday, March 15, 2017Biocept Inc a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of cancer patients announces a collaboration with Catalyst Pharmaceuticals for the provisio...
Mylan Announces Global Settlement and License Agreements with Genentech and Roche on Herceptin®
Tuesday, March 14, 2017Mylan NV today announced that Mylan has agreed to the terms of a global settlement with Genentech Inc and F HoffmannLa Roche Ltd in relation to patents for Herceptin trastuzumab which provides Mylan with global licenses for its trastuzumab product...
Charles River Laboratories and Chiesi Farmaceutici SpA Announce Extension of Integrated Respiratory Drug Discovery Program
Tuesday, March 14, 2017Charles River Laboratories International Inc a leading earlystage contract research organization CRO today announced that it has extended its longstanding strategic integrated drug discovery partnership with Chiesi Farmaceutici SpA in the field of re...
NeoGenomics and Definiens Enter Into Agreement to Develop Novel Assays for Clinical Trials & Clinical Testing
Tuesday, March 14, 2017NeoGenomics Inc a leading provider of cancerfocused genetic testing services and Definiens the leader in Tissue Phenomics solutions from biomarker discovery to meaningful diagnostics today announced that they have expanded their alliance to develop a...
Midatech Announces Successful Initial Scale-Up of Its Sustained Release Manufacturing Facility
Monday, March 13, 2017Midatech Pharma the international specialty pharmaceutical company focused on developing and commercialising products in oncology is pleased to announce the successful initial scaleup and regulatory inspection of its stateoftheart manufacturing site...
Mylan Launches Generic Pristiq® Tablets
Saturday, March 11, 2017Mylan NV announced the US launch of Desvenlafaxine Extendedrelease Tablets mg and mg a generic version of Pfizers Pristiq Tablets Mylan received final approval from the US Food and Drug Administration FDA for its Abbreviated New Drug Application AN...
BioreclamationIVT Acquires TransCell Science
Friday, March 10, 2017BioreclamationIVT has acquired TransCell Science a privately held contract research organization CRO specializing in the use of primary cells for phenotypic screening assays With its scientific expertise in the areas of cell culture and cellbased ass...
